Gene-edited pigs could be harvested for human organ transplants

The number of patients on transplant lists far outweighs the number of available organs, but a new development in gene editing could change things. Researchers have created gene-edited piglets without viruses that can cause diseases in humans. These animals could be harvested for their organs to be transplanted into human patients.

“They could be a real game changer,” said David Klassen, MD, CMO at the United Network for Organ Sharing, a private, nonprofit organization that manages the nation’s transplant system.

The organs could be used as liver, heart and other transplantations in the hopes that to reduce transplant waiting lists.

Read the full story below:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”